Applied DNA Sciences Inc. (APDN)
| Bid | 0.92 |
| Market Cap | 5.98M |
| Revenue (ttm) | 3.74M |
| Net Income (ttm) | -8.53M |
| EPS (ttm) | -32.5 |
| PE Ratio (ttm) | -0.03 |
| Forward PE | -0.16 |
| Analyst | Buy |
| Ask | 0.92 |
| Volume | 618,959 |
| Avg. Volume (20D) | 1,260,845 |
| Open | 0.88 |
| Previous Close | 0.88 |
| Day's Range | 0.89 - 0.92 |
| 52-Week Range | 0.72 - 237.50 |
| Beta | 0.84 |
About APDN
Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets; and for supply chain security, anti-counterfeiting, and anti-theft technology purposes. The company's supply chain security and product authentication solutions include SigNature molecular tags that provide forensic power and protection ...
Analyst Forecast
According to 1 analyst ratings, the average rating for APDN stock is "Buy." The 12-month stock price forecast is $75, which is an increase of 8052.17% from the latest price.
Stock Forecasts
3 weeks ago · accessnewswire.com
Applied DNA Regains Compliance with Nasdaq Minimum Bid Price RequirementSTONY BROOK, NY / ACCESS Newswire / April 8, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in PCR-based DNA technologies, today announced that on April 7, 2025, it received a...
1 month ago · accessnewswire.com
Applied DNA Announces 1-For-50 Reverse Stock Split Effective March 14, 2025STONY BROOK, NY / ACCESS Newswire / March 12, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA or the "Company"), a leader in PCR-based DNA technologies, today announced that it will effec...
2 months ago · seekingalpha.com
Applied DNA Sciences, Inc. (APDN) Q1 2025 Earnings Call TranscriptApplied DNA Sciences, Inc. (NASDAQ:APDN ) Q1 2025 Earnings Conference Call February 13, 2025 4:30 PM ET Company Participants Sanjay Hurry - Executive Director, IR & Corporate Communications Beth Jantz...
2 months ago · accessnewswire.com
Applied DNA Reports First Quarter Fiscal 2025 Financial Results and Highlights Operational Progress- Announces Exit of DNA Tagging and Security Products and Services Business Segment - - Workforce Reduction of 20% of Headcount Implemented in January - - GMP Site 1 Facility Complete and Certified fo...
2 months ago · accessnewswire.com
Applied DNA Reminds Shareholders to Vote Ahead of Special Meeting on February 14STONY BROOK, NY / ACCESS Newswire / February 11, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today issued a reminder to it...